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The identification of the structures recognized by syngeneic cytotoxic T  lympho- 
cytes (CTL) 1 is complicated by the necessity for these cells to recognize, on the target 
cell surface, both antigen  (Ag) and certain products of the major histocompatibility 
complex,  rather  than  the  Ag  alone  (1). To  develop  a  general  procedure  for  the 
identification  of the Ag  (such  as those on  virus  infected or tumor ceils),  we have 
investigated  the  ability  of synthetic  phospholipid  vesicles  (liposomes),  containing 
purified Ag, to specifically elicit the development of the corresponding CTL. We show 
here that CTL primed in vivo can be stimulated in a secondary response by liposomes 
containing both a single purified protein of vesicular stomatitis virus (VSV), the G or 
glycoprotein, and solubilized membrane proteins from cells of the same H-2 haplotype 
as the CTL and the VSV-infected target cells. Responder cells from (H-2  d ×  H-2  ~) 
hybrid mice (d ×  b) and liposomes that contained G protein plus membrane proteins 
from cells of the parental H-2 haplotype, d or b, provided particularly striking evidence 
that CTL precursors were stimulated by intact liposomes, rather than by substances 
that  were  released  from  liposomes  and  subsequently  adsorbed  onto  cells  of the 
responder population. 
Materials and Methods 
Mice  and  Cultured Cells.  H-2  haplotypes  are  in  parentheses.  BALB/cAnN  (d)  and  H-2 
congenic  BALB.B  (b)  mice  were  bred  at  the  Center  for  Cancer  Research,  Massachusetts 
Institute  of Technology.  (BALB/cAnN  ×  BALB.B)  F1  hybrids  were  produced  at  Bowman 
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Gray School of Medicine. The  following cell lines were  maintained in culture:  P815  (d), a 
mastocytoma of DBA/2 origin, generously provided by M. Bevan, M.I.T.; EL-4 (b), a thymus 
lymphoma  of C57BL/6  (B6)  origin,  kindly  donated  by  H.  Winn,  Massachusetts  General 
Hospital; MC57G  (b), a  macrophage-like cell line of B6 origin, kindly provided by Barbara 
Knowles, Wistar Institute; 3T3 fibroblasts were derived from BALB/c (d), BALB.B (b), and 
BALB.K (k) mice (2). 
Viral and Cell Membrane Proteins.  VSV and the virion glycoprotein (G protein) were produced 
and isolated as described (2, 3),  In sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
the G protein migrated as a single band; its concentration was determined by the Lowry et al. 
method (4). 
Plasma membranes were prepared as described (5). Briefly, ca. 6  ×  109 cells were disrupted 
by gentle homogenization in  10 mM Tris (pH  7.8),  10 mM NaCI,  1 mM MgCI2, and  I  mM 
phenymethyisulfonylfluoride. After low speed  (400  g)  centrifugation  to  remove  nuclei  and 
intact cells, crude membranes were obtained by centrifuging the supernate at 20,000 g for 0.5 
h. The resulting pellet was resuspended in 40% sucrose in 10 mM Tris (pH 7.4), overlaid with 
30% sucrose in  10 mM Tris (pH  7.4),  and spun at 80,000 g  for  18 h.  The turbid interfacial 
band,  containing  plasma  membrane  (6),  was  removed  and  freed  of sucrose  by  repeated 
centrifugations. The washed membranes, resuspended in PBS, were used immediately or frozen 
at -70 °. The membranes were stirred overnight at 22°C with 0.5%  Na deoxycholate, 0.45 M 
KCI, 10 mM Tris, pH 7.9; then, after centrifugation at  180,000 g for 1 h, the protein content 
of the supernate (plasma membrane proteins or PMP) was determined by measuring optical 
density, assuming 1 mg of protein/ml had an absorbance at 280 nm of 1.0. P815 and EL4 cells 
were used, respectively, as sources of PMP of H-2  a and H-2  b type. 
Preparations of Phospholipid Vesicles.  A modified procedure of Kagawa and Racker was used 
(7).  Dimyristoylphosphatidylcholine (DMPC),  purchased  from  Calbiochem-Behring Corp., 
American Hoechst Corp.  (San  Diego, Calif.), was used without  further purification. Cholic 
acid, purchased from Sigma Chemical Co.  (St.  Louis, Mo.), was decolorized with activated 
charcoal and recrystallized twice from acetone. In a typical preparation, 0.6 mg DMPC, dried 
from chloroform under N2, was suspended in 0,6 ml of cholic acid (4 mg/ml, pH  7.5) with a 
vortex mixer and was then sonicated for 15 min. After adding 10-20 #g of G protein (in 0.1 ml) 
and/or  300-400  #g of solubilized plasma membrane  proteins  (in  3-4  ml)  the  mixture was 
incubated for 1 h and then dialyzed overnight (all at room temperature) against 4 liters of 10 
mM Tris, pH 7.5. To facilitate removal of deoxycholate, 20 ml (packed volume) of SM-2 Bio- 
Beads  (Bio-Rad  Laboratories,  Richmond,  Calif.)  were  added  to  the  dialysis buffer.  The 
liposomes that formed were packed by centrifugation (40,000  g), resuspended in  100 #1 PBS, 
and sterilized under UV light (4 h, 15 cm from a Westinghouse sterilamp G 15T8, Westinghouse 
Electric Corp., Pittsburgh, Pa.) before being added to spleen cell cultures. Through the use of 
12~I-labeled G  protein and lsXI-plasma membrane proteins (PMP), it was found that ~60% of 
the  added G  protein and  ~30%  of the  added  PMP  were  incorporated into  the  liposomes, 
whether G  protein and PMP were incorporated into liposomes individually or together. The 
liposomes were shown by electron microscopy to range in diameter from 600 to  1,000 A  (D. 
Loh, unpublished material, 11) and to be unilamellar (11). 
Immunization and Generation of Effector Cells.  Mice were injected (primed) intravenously with 
0.5-1.0  )<  10  7 plaque-forming units (PFU) of plaque-purified VSV (not inactivated) in PBS. 
5-10 wk later, 8  ×  106 spleen cells, cleared of erythrocytes, were cultured in vitro with UV- 
inactivated VSV (3-6 ×  107 PFU before inactivation) or with liposomes containing one of the 
following: (a) G  protein (ca 1.5 #g) plus PMP  (10 #g), or (b) G  protein alone (1.5 p,g), or (c) 
PMP alone (10/~g), or (d) a mixture of (b) and (c). After 5 d, the cells were tested for ability to 
lyse 51Cr-labeted VSV-infected target cells (2). Target cells were prepared by infecting P815 or 
MC57G cells or various congenic BALB 3T3 flbroblasts with VSV at a multiplicity of 20-25; 
3.5 hrs later the cells were labeled with 51Cr (8).  5  ×  104 target cells and various numbers of 
effector cells were  incubated  for  6  h  in  12  ×  75-mm  round-bottom  plastic tubes  (Falcon 
Labware, Div. of Becton, Dickinson, & Co., Oxnard, Calif.) in a final vol of 400 p.l. Controls for 
the effector cells in each assay included spleen cells from both primed and umprimed mice, 
cultured for 5 d in the absence of Ag (VSV or G protein or PMP). 
Specific lysis resulting from the secondary stimulus was calculated as 100 (E-C/100-C) where DENNIS  LOH  ET  AL.  1069 
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Elc.  1.  H-2 restriction of the ]ytic activit  7 of anti-VSV CTLs elicited by phospholipld vesicles. 
Target cells  were SlCr-labeled VSV-infected P815  (H-2  a)  or MC57G  (H-2~  cells.  A.  Secondary 
response by spleen cells  from VSV-primed BALB/c  (H-2  d)  mice elicited in culture with vesicles 
containing VSV G  protein and plasma membrane proteins from H-2  d cells  (P815).  B. Secondary 
response by spleen cells  from VSV-primed BALB.B (H-2  b) mice elicited in culture with vesicles 
containing VSV G protein and plasma membrane proteins from H-2  b cells (EL-4). 
E is the percentage of 5aCr-released by primed and boosted spleen cells and C is the percentage 
of 5~Cr-released by primed, but not boosted, spleen cells. Values for C were typically 15-20%; 
in control assays with nonprimed and nonboosted spleen cells, 10-20% of target cell 5~Cr was 
usually released. 
Media.  The  media  used  for cell  culture  and  for cytotoxicity assays  were  RPMI-1640 
supplemented as described  (2). 
Results and Discussion 
A previous study of target cells infected with temperature-sensitive mutants of VSV 
showed  that  anti-VSV  CTL lyse only target  cells  that  have  both  the correct  H-2 
haplotype and G on the target cell surface (2). To determine whether purified G can 
elicit the formation of anti-VSV CTLs, we examined the response of spleen cells from 
VSV-primed mice to liposomes containing G. Spleen cells removed 6 d after a single 
intravenous injection of VSV  have considerable CTL activity; however, 5-6 weeks 
later CTL activity is no longer detectable. To stimulate a  secondary CTL response, 
spleen cells taken 6-8 w after one i.v.  injection of VSV were incubated for 5 d  with 
liposomes containing purified G protein, with or without cell membrane proteins; the 
spleen cells were then tested on VSV-infected target cells with various H-2 haplotypes. 
As is shown in Fig.  1, when primed spleen cells from BALB/c (H-2  d)  mice were 
incubated  with  liposomes that  contained both purified G  and  membrane proteins 
from H-2  a cells, they elicited CTLs that were VSV-specific and H-2 restricted: they 
lysed VSV-infected H-2  a cells (P815) but neither VSV-infected H-2  b cells (MC57G) 
(Fig.  1 A) nor uninfected P815 cells (not shown). Parallel results were obtained with 
primed  spleen cells from congenie BALB.B  (H-2  b)  mice:  the  CTL they formed in 
response to liposomes having G  and PMP from H-2  b cells lysed VSV-infected H-2  b 
cells (MC57G), not VSV-infected H-2 a cells (P815)  (Fig.  1 B). 
The triggering of the secondary CTL response also required a  match between the 
H-2 haplotype of the primed spleen cells and the cells whose membrane proteins were 
included, with G, in the liposomes. As is shown in Fig. 2, anti-VSV CTLs were elicited 1070  PHOSPHOLIPID  VESICLES ELICIT CYTOTOXIC T  LYMPHOCYTES 
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Etc.  2.  H-2 restriction in the generation ofanti-VSV CTLs by incubating spleen cells from VSV- 
primed BALB/c  (H-2  d)  and BALB.B  (H-2  b)  mice with phospholipid vesicles containing VSV G 
•  d  protein  and plasma membrane proteins  from uninfected  P815  (H-2)  cells or  EL-4  (H-2  h) cells, 
designated G/PMP-H-2 d (O) and G/PMP-H-2 b (A), respectively. A. The primed mice were BALB/ 
c and the target cells were 51Cr-labeled VSV-infected P815 cells (H-2d). B. The primed mice were 
BALB.B and the target cells were 51Cr-labeled VSV-infected MC57G cells (H-2b). 
in primed spleen cells from H-2  d mice (BALB/c) by liposomes with G  +  PMP from 
H-2  d cells,  not  by liposomes with  G  +  PMP  from H-2  b cells,  and  the reverse was 
observed with primed spleen cells from H-2  b mice (BALB.B). These results strongly 
imply that  CTL precursors  were stimulated  by intact  liposomes:  if G  protein  was 
released  and  then  elicited  CTL,  the  H-2  haplotype  of the  cells  whose  membrane 
proteins were incorporated into liposomes would have been irrelevant. 
The  effectiveness of intact  liposomes was  brought  out  especially forceably with 
primed  spleen  cells  from  VSV-infected  (BALB/c  X  BALB.B)F1  hybrid  mice,  for 
simplicity called d  X  b. Anti-VSV CTLs could be elicited in these d  X  b spleen cells 
with G-bearing liposomes that contained  membrane proteins  from cells with either 
parental H-2 haplotype, H-2  b or H-2  a (Table I). There is considerable evidence that 
Ft hybrids form two sets of Ag-specific CTLs, one for Ag +  H-2 of one parent and the 
other for Ag  +  H-2 of the other parent  (9).  In accord with this evidence, the d  X  b 
CTL elicited with liposomes that contained G  +  PMP  from H-2  d cells lysed VSV- 
infected target cells with  the H-2  d haplotype, not  targets with  the  H-2  b haplotype, 
whereas the d  X  b CTL elicited with G  +  H-2  b membrane proteins lysed only VSV- 
infected targets with the H-2  b haplotype (Table I). Again, if d  ×  b CTL were elicited 
by the G protein released from disintegrated liposomes it would be expected that the 
resulting anti-VSV CTLs would have lysed infected H-2  d and H-2  b targets, regardless 
of which liposomes elicited the killer cells. It has been proposed that T  cells recognize 
not intact Ag molecules but processed Ag fragments on macrophages (e.g., reference 
10). The findings in Table I suggest, however, that Ag processing is not necessary, at 
least for the specific stimulation of secondary CTL responses• 
In contrast to the stimulator activity of liposomes with G  +  PMP (from cells of the 
correct  H-2  haplotype),  liposomes  with  G  alone,  or  with  the  PMP  alone,  were 
ineffective. A mixture of the G-alone and the PMP-alone liposomes was also ineffective 
(Fig. 3). This means that for effective interaction with CTL precursors the G and H- DENNIS  LOH  ET AL.  1071 
TABLE  1 
Spleen CeUs  from Primed (H-2 a ×  H-2  ~) Hybrid Mice Respond in Culture to Phospholipid Vesicles 
Containing G Glycoprotein and Plasma Membrane Proteins  from  Uninfected Cells of Parental H-2 
Haplotype 
Liposomes contain 
Percent specific lysis of VSV-infected target cells* 
3T3 Fibroblasts 
P815  MC57G  BALB/c  BALB.B  BALB.K:I: 
(H-2 a)  (H-2  b)  (H-2  a)  (H-2  b)  (H-2 k) 
G alone  4.8  4.6  5.0  5.2  -2.4 
G  +  membrane proteins from H-2  a cells  46.7  3.5  18.8  5.1  0.3 
G  +  membrane proteins from H-2  b cells  5.0  43.9  2.7  24.0  0.2 
* Additional controls (A. H. Hale, unpublished material) were carried out by incubating  spleen cells from 
VSV-primed (H-2  a ×  H-2  b) F1 mice with the following mixtures of liposomes, containing  G protein and/ 
or  plasma  membrane proteins  from  H-2  a  or  H-2  b cells  (designated  as  PMP-H-2  a  or  PMP-H-2 b, 
respectively): 
(No. 1) (G +  PMP-H-2  b) liposomes mixed with (G +  PMP-H-2  a) liposomes 
(No. 2) (G +  PMP-H-2  b) liposomes mixed with (PMP-H-2  a) liposomes 
(No. 3) (G +  PMP-H-2  a) liposnmes mixed with (PMP-H-2  b) liposomes. 
Percent specific lysis of VSV-infected  H-2  a and H-2  b target cells (P815 and MC57G,  respectively) were 
as follows (at E:T ratio 100:1): 
mixture no. 1--26.8, $7.3 
mixture no. 2--6.7,  41.8 
mixture no. 3--31.8, 10.2. 
In these  controls  the  liposomes were  prepared  with  egg  lecithin-cholesterol  (70:30, wt/wt)  and the 
indicated proteins in 0.2% deoxycholate;  vortex mixing was used to disperse the lipids and dialysis to 
remove the deoxycholate. 
When tested  separately these targets  were shown  to be specifically lysed (38.4%) by primary response 
CTLs spleen cells taken from BALB.K mice 6 d after an intravenous injection of 2 ×  107 PFU of VSV. 
2 molecules had to be in the same liposome, or closer together than 600-1,000 A, the 
diameter of the unilamellar vesicles used in this study (11, and also A. H. Ross and H. 
G. Khorana, unpublished results). 
For comparison with liposomes,  UV-inactivated VSV  and soluble G  protein, not 
incorporated  into vesicles, were  also  tested  on VSV-primed  spleen cells. The  inacti- 
vated  virus  regularly  elicited  as  much  CTL  activity  as  active  liposomes  (data  not 
shown).  2 In contrast, G  protein, added at 5,  10, 50, and  100 #g/well, failed to elicit a 
significant response (data not shown); however, in a  few trials, where lysis elicited by 
liposomes (with G  and PMP  from cells with the correct H-2 haplotype) was relatively 
high  (e.g.,  60-70%  specific  lysis),  some  cytolytie  activity was  elicited  by soluble G 
protein, but the response was low  (ca.  10-15%)  and not reproducible. 
Two previous studies showed that Ag-containing liposomes can elicit CTL. Purified 
2 In many trials stimulation of the primed spleen cells by the inactivated virus also resulted  in a low 
level of lysis of uninfected P815 cells, especially when the activity elicited againt VSV-infected  P815 was 
high (e.g., 60% specific lysis). A definite explanation for the low-level, apparently nonspecific  cytotoxic 
activity is not available (but see ref. 21 for one suggestion). 1072  PHOSPHOLIPID  VESICLES  ELICIT  CYTOTOXIC  T  LYMPHOCYTES 
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FxG.  3.  Stimulation of CTL activity in spleen cells  from VSV-primed BALB/c  (H-2  d)  mice by 
variously prepared liposomes:  0, vesicles with VSV G protein +  membrane proteins from P815 (H- 
2  d) cells [G/PMP-H-2d]. A, vesicles with G protein only, or only with P815  membrane proteins, or 
a mixture of the two kinds of vesicles (G only and PMP only). 
histocompatibility leukocyte antigens (HLA) in liposomes were used by Englehard et 
al.  (12)  to stimulate the development of mouse CTL that specifically lysed human 
cells of the correct HLA type, and Finberg, et al.  (13)  used liposomes containing a 
mixture of Sendai virus Ags (plus cell membrane proteins of the correct H-2 haplotype) 
to elicit H-2 restricted CTLs that  lysed Sendai virus-infected target cells. However, 
Sendai virus proteins cause cells to fuse (14), and probably liposomes and cells to fuse, 
whereas VSV  and  purified G  protein  have no  fusing activity  (15).  It  is  not  clear, 
therefore, that  Sendai-liposomes and the VSV-liposomes described here function in 
precisely the same manner. 
Even  without  being  incorporated  into  lipid  vesicles, some  isolated  proteins  can 
apparently elicit H-2 restricted CTLs (16-20). It is probable that these proteins bind 
to cells of the responder population and that the bound protein, through proximity 
with the appropriate H-2 encoded surface molecules on the same cells, is effectively 
presented to CTL precursors.  Alternatively, it  has been suggested  that  the  soluble 
proteins  (bound  or unbound)  might  stimulate  T  helpers  to secrete mediators that 
nonspecifically trigger the  differentiation of any  CTL precursors  in  the  responder 
population (21). In the present study, however, there was a striking difference between 
soluble G and the G that was incorporated (along with cell membrane proteins) into 
liposomes: whereas  1.5 #g of G  in liposomes (with H-2 proteins) consistently elicited 
secondary  CTL  (Figs.  1-3),  soluble  G,  in  amounts  up  to  100  /~g  was  generally 
ineffective. 
The identity of the Ags (and antigenic determinants) that determine the specificity 
of CTL and other T  cells has been difficult to establish. With the finding that purified 
protein in intact liposomes (along with the appropriate H-2 products) can specifically DENNIS LOH  ET AL.  1073 
elicit  secondary CTL it may be possible to define unambiguously not  only the Ag 
molecules but the antigenic determinants that are recognized by the T  cells. 
Summary 
Synthetic  phospholipid  vesicles  (liposomes)  containing  the  purified  glycoprotein 
((3) of vesicular stomatitis virus (VSV) and solubilized membrane proteins from cells 
of the  appropriate  H-2  haplotype elicited  H-2-restricted  cytotoxic T  lymphocytes 
(CTL) that lysed VSV-infected target cells. The CTL were elicited by intact liposomes, 
not by released components. Thus, when spleen cells from VSV-primed H-2  d ×  H-2  h 
hybrid mice were stimulated with liposomes having G protein  +  membrane proteins 
from cells with  one of the  parental  H-2  haplotypes,  the  resulting CTL lysed only 
VSV-infected target cells with that parent's H-2 type. This result argues against the 
view that T  cells in general recognize only processed antigenic fragments on macro- 
phages. Moreover, liposomes were only effective when G  protein and cell membrane 
proteins  were  included  in  the  same  vesicles.  This  result  suggests  that  for effective 
interaction  with CTL precursors  the  antigen  (G protein)  and  products  of the  H-2 
complex must  be closer to each  other  than  600-1,000  A, the  diameter of the lipid 
vesicles used in this study. 
Received for publication  29 May  1979. 
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